Tech Company Financing Transactions
Athletigen Funding Round
Exponent.VC and private investors participated in a $1.6 million Seed capital raise for Athletigen. The funding round was announced on 1/5/2016.
Transaction Overview
Company Name
Announced On
1/5/2016
Transaction Type
Venture Equity
Amount
$1,550,000
Round
Seed
Investors
Exponent.VC (Lead Investor) (Pat Wilkison)
Proceeds Purpose
Athletigen will be using the funds to advance its human performance platform to help athletes unlock their potential.
Company Information
Company Status
Private & Independent
Industry
Consumer
Mailing Address
5415 Spring Garden Rd. 601
South Halifax NS, B3J 1G1
Canada
South Halifax NS, B3J 1G1
Canada
Phone
Undisclosed
Website
Email Address
Overview
Athletigen helps you achieve your full potential through personalized reports and recommendations based on how your genetics influence performance.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeremy Koenig
Chief Operating Officer
Scott Logan
Chief Scientific Officer
Ian Zinck
VP - Engineering
Darrell Snow
Browse more venture capital transactions:
Prev: 1/5/2016: TARA Biosystems venture capital transaction
Next: 1/5/2016: Deciphera Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs